Cargando…

Maintenance antipsychotic treatment versus discontinuation strategies following remission from first episode psychosis: systematic review

BACKGROUND: Understanding the relative risks of maintenance treatment versus discontinuation of antipsychotics following remission in first episode psychosis (FEP) is an important area of practice. METHOD: A systematic review and meta-analysis. Prospective experimental studies including a parallel c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thompson, Andrew, Winsper, Catherine, Marwaha, Steven, Haynes, Jon, Alvarez-Jimenez, Mario, Hetrick, Sarah, Realpe, Alba, Vail, Laura, Dawson, Sarah, Sullivan, Sarah A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034451/ https://www.ncbi.nlm.nih.gov/pubmed/29988997 http://dx.doi.org/10.1192/bjo.2018.17

Ejemplares similares

Discontinuing Antipsychotic Medication After Remission from First-Episode Psychosis: A Survey of Psychiatrists’ Attitudes in Taiwan
por: Yen, Ko, et al.
Publicado: (2022)

Second-Generation Antipsychotic Discontinuation in First Episode Psychosis: An Updated Review
por: Miller, Brian J., et al.
Publicado: (2011)

Childhood trauma, antipsychotic medication, and symptom remission in first-episode psychosis
por: Ottesen, Akiah, et al.
Publicado: (2023)

Effectiveness of antipsychotics used in first-episode psychosis: a naturalistic cohort study
por: Whale, Richard, et al.
Publicado: (2016)

Schneider’s first-rank symptoms as predictors of remission in antipsychotic-naive first-episode psychosis
por: Malinowski, Fernando R., et al.
Publicado: (2019)

Remission from antipsychotic treatment in first episode psychosis related to longitudinal changes in brain glutamate
por: Merritt, Kate, et al.
Publicado: (2019)

T121. RATES AND PREDICTORS OF RELAPSE FOLLOWING DISCONTINUATION OF ANTIPSYCHOTIC MEDICATION AFTER A FIRST EPISODE OF PSYCHOSIS
por: Bowtell, Meghan, et al.
Publicado: (2018)

A systematic review of comparative time to all cause discontinuation of antipsychotic medications in first episode psychosis
por: Brooke, Alice, et al.
Publicado: (2021)

S145. ANTIPSYCHOTIC DISCONTINUATION IN FIRST EPISODE PSYCHOSIS: [18F]DOPA AND [11C]RACLOPRIDE PET STUDY
por: Kim, Euitae
Publicado: (2018)

To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial
por: Begemann, Marieke J. H., et al.
Publicado: (2020)

Multidimensional predictors of negative symptoms in antipsychotic-naive first-episode psychosis
por: Toll, Alba, et al.
Publicado: (2022)

Antipsychotic prescribing choices in patients with First Episode Psychosis
por: Fallon, J., et al.
Publicado: (2022)

Social cognition in patients with first episode of psychosis in remission
por: Sen, Mahadev Singh, et al.
Publicado: (2020)

Achievement of remission after first-episode psychosis in youth
por: Kaleda, V., et al.
Publicado: (2021)

Gradients of striatal function in antipsychotic-free first-episode psychosis and schizotypy
por: Oldehinkel, Marianne, et al.
Publicado: (2023)

S227. A PROPOSED ALTERNATIVE BETWEEN DISCONTINUATION AND MAINTENANCE OF ANTIPSYCHOTICS: A GUIDED DOSE REDUCTION TRIAL FOR PATIENTS WITH REMITTED PSYCHOSIS
por: Liu, Chen-Chung
Publicado: (2018)

Cognitive impairment in first-episode mania: a systematic review of the evidence in the acute and remission phases of the illness
por: Daglas, Rothanthi, et al.
Publicado: (2015)

Dose Reduction/Discontinuation of Antipsychotic Drugs in Psychosis; Effect on Cognition and Functional Outcomes
por: Omachi, Yoshie, et al.
Publicado: (2018)

S122. TEN-YEAR FOLLOW-UP AFTER FIRST EPISODE PSYCHOSIS: FOCUSED ON LOW DOSE ANTIPSYCHOTIC MAINTENANCE AND FUNCTIONING
por: Liu, Chen-Chung, et al.
Publicado: (2020)

Different trajectories of the first-episode psychosis remission in young adults
por: Kaleda, V., et al.
Publicado: (2022)

T54. TAILOR – TAPERED DISCONTINUATION VERSUS MAINTENANCE THERAPY OF ANTIPSYCHOTIC MEDICATION IN PATIENTS WITH NEWLY DIAGNOSED SCHIZOPHRENIA SPECTRUM DISORDERS IN REMISSION OF PSYCHOTIC SYMPTOMS
por: Dolmer, Signe, et al.
Publicado: (2018)

Antipsychotic pharmacogenomics in first episode psychosis: a role for glutamate genes
por: Stevenson, J M, et al.
Publicado: (2016)

The benefits of the Mediterranean diet in first episode psychosis patients taking antipsychotics
por: Vassilopoulou, Emilia, et al.
Publicado: (2022)

Challenging the Minimum Effective Antipsychotic Dose During Maintenance: Implications From 10-Year Follow-Up of First Episode Psychosis
por: Liu, Chen-Chung, et al.
Publicado: (2021)

Maintenance treatment with quetiapine versus discontinuation after one year of treatment in patients with remitted first episode psychosis: randomised controlled trial
por: Chen, Eric Y H, et al.
Publicado: (2010)

Ethnicity and pathways to care during first episode psychosis: the role of cultural illness attributions
por: Singh, Swaran P., et al.
Publicado: (2015)

Antipsychotic Treatment Reduces Indices of Oxidative Stress in First-Episode Psychosis Patients
por: Kriisa, Kärt, et al.
Publicado: (2016)

A Meta-Analysis of the Influence of Antipsychotics on Cytokines Levels in First Episode Psychosis
por: Marcinowicz, Piotr, et al.
Publicado: (2021)

Abnormal reward prediction-error signalling in antipsychotic naive individuals with first-episode psychosis or clinical risk for psychosis
por: Ermakova, Anna O., et al.
Publicado: (2018)

Development and validation of a non-remission risk prediction model in First Episode Psychosis: An analysis of two longitudinal studies
por: Leighton, Samuel, et al.
Publicado: (2021)

Tardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics
por: Adam, Usman U, et al.
Publicado: (2014)

The effect of second-generation antipsychotics on hippocampal volume in first episode of psychosis: longitudinal study
por: Bodnar, Michael, et al.
Publicado: (2016)

S19. THE ROLE OF ACE AS POSSIBLE BIOMARKER FOR TREATMENT RESISTANCE TO ANTIPSYCHOTICS IN FIRST EPISODE OF PSYCHOSIS
por: Luisa, Longo, et al.
Publicado: (2020)

Prescribing pattern of antipsychotic medication for first-episode psychosis: a retrospective cohort study
por: Keating, Dolores, et al.
Publicado: (2021)

Macroscale EEG characteristics in antipsychotic-naïve patients with first-episode psychosis and healthy controls
por: Dominicus, L. S., et al.
Publicado: (2023)

Tapered discontinuation vs. maintenance therapy of antipsychotic medication in patients with first-episode schizophrenia: Obstacles, findings, and lessons learned in the terminated randomized clinical trial TAILOR
por: Stürup, Anne Emilie, et al.
Publicado: (2022)

Psychosis breakthrough on antipsychotic maintenance medication (BAMM): what can we learn?
por: Rubio, Jose M., et al.
Publicado: (2017)

Hippocampal glutamate and hippocampus subfield volumes in antipsychotic-naive first episode psychosis subjects and relationships to duration of untreated psychosis
por: Briend, Frédéric, et al.
Publicado: (2020)

White Matter Integrity, Duration of Untreated Psychosis, and Antipsychotic Treatment Response in Medication-Naïve First Episode Psychosis Patients
por: Kraguljac, Nina Vanessa, et al.
Publicado: (2020)

Can cognitive insight predict symptom remission in a first episode psychosis cohort?
por: O’Connor, Jennifer A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ndre5sljc6d1qdl0l0rg98klsu